Regadenoson Infusion of Marginalized Donor Lungs in an EVLP System
Condition(s):Lung TransplantLast Updated:August 15, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Lung TransplantLast Updated:August 15, 2023Recruiting
Condition(s):Atrial Fibrillation; Coronary Artery DiseaseLast Updated:December 13, 2017Completed
Condition(s):Coronary Artery DiseaseLast Updated:October 3, 2017Unknown status
Condition(s):Left Ventricular Systolic Dysfunction; Sudden Cardiac DeathLast Updated:October 18, 2022Completed
Condition(s):Blood Brain Barrier DefectLast Updated:November 20, 2018Completed
Condition(s):Coronary Artery DiseaseLast Updated:May 11, 2018Completed
Condition(s):Myocardial Ischemia; Coronary Artery DiseaseLast Updated:November 22, 2023Recruiting
Condition(s):Coronary Artery Disease; Myocardial Perfusion AbnormalitiesLast Updated:October 3, 2023Completed
Condition(s):Coronary Artery DiseaseLast Updated:June 23, 2017Completed
Condition(s):Coronary Artery DiseaseLast Updated:October 25, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.